Saturday, October 31, 2026

EUR/GBP Bullish Momentum: 0.89% Up In The Last 5 Sessions

EUR/GBP Bullish Momentum: 0.89% Up In The Last 5 Sessions

(VIANEWS) - EUR/GBP (EURGBP) has been up by 0.89% for the last 5 sessions. At 15:10 EST on Sunday, 26 March, EUR/GBP (EURGBP) is $0.88.

EUR/GBP's yearly highs and lows, it's 6.775% up from its 52-week low and 4.612% down from its 52-week high.

Volatility

EUR/GBP's last week, last month's, and last quarter's current intraday variation average was 0.25%, 0.01%, and 0.32%, respectively.

EUR/GBP's highest amplitude of average volatility was 0.43% (last week), 0.35% (last month), and 0.32% (last quarter), respectively.

News about

  • Usd/jpy steadies near six-week low under 131.00 on mixed Japan inflation, US data eyed. According to FXStreet on Friday, 24 March, "Moving on, preliminary readings of the US S&P Global PMIs for March and the Durable Goods Orders for February will be crucial for the USD/JPY pair traders to watch for clear directions.", "A successful rebound from the 10-week-old ascending support line, around 130.40 by the press time, allows USD/JPY to challenge the downward-sloping resistance line stretched from March 08, near 131.25 at the latest."
  • Usd/jpy remains heavily offered near 130.00 mark, its lowest level since February 10. According to FXStreet on Friday, 24 March, "This, along with the US bond yields, might influence the USD price dynamics and provide some impetus to the USD/JPY pair. ", "This results in a further narrowing of the US-Japan rate differential, which is seen as another factor that drives flows towards the JPY and contributes to the heavily offered tone surrounding the USD/JPY pair."
  • Usd/jpy to trade down to the YTD lows between 127-128 relatively quickly – MUFG. According to FXStreet on Friday, 24 March, "The scale of easing now priced for this year (Dec '23 fed funds future at 4.10%) leaves the US dollar vulnerable and we are likely to see USD/JPY trading down to the YTD lows between 127-128 relatively quickly.", "Understandably, the Fed and the drop in yields in the US is getting the attention as a key factor in pushing USD/JPY lower but the energy story will certainly add to positive JPY momentum this year."
  • Usd/jpy price analysis: bears poke 10-week-old support line near 130.50. According to FXStreet on Friday, 24 March, "Following that, the 130.00 round figure and multiple levels marked in February near 129.30, as well as near 128.00, could test the USD/JPY bears before directing them to the yearly low of 127.21.", "Alternatively, USD/JPY recovery can initially aim for the 50-DMA hurdle of 132.60. "

More news about EUR/GBP (EURGBP).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com